Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-09-09 Sale |
2022-09-09 4:14 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
775 | $227.17 | $176,057 | 76,401 (Direct) |
View |
2022-09-08 Sale |
2022-09-09 4:14 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
26,402 | $224.73 | $5,933,438 | 237,511 (Direct) |
View |
2022-08-16 Sale |
2022-08-17 4:41 pm |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
6,698 | $252.86 | $1,693,689 | 37,970 (Direct) |
View |
2022-08-11 Sale |
2022-08-12 4:49 pm |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
4,840 | $254.32 | $1,230,886 | 19,670 (Direct) |
View |
2022-08-04 Sale |
2022-08-05 4:29 pm |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
3,357 | $243.01 | $815,785 | 30,735 (Direct) |
View |
2022-08-03 Sale |
2022-08-04 4:32 pm |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
2,000 | $240.4 | $480,800 | 17,733 (Direct) |
View |
2022-08-01 Sale |
2022-08-02 5:26 pm |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
2,000 | $220 | $440,000 | 37,187 (Direct) |
View |
2022-07-21 Sale |
2022-07-22 4:25 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
24,802 | $200 | $4,960,400 | 263,913 (Direct) |
View |
2022-05-25 Sale |
2022-05-26 5:17 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
14,715 | $150.51 | $2,214,819 | 76,532 (Direct) |
View |
2022-03-01 Sale |
2022-03-02 9:14 pm |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
2,000 | $198.03 | $396,060 | 1,457 (Direct) |
View |
2021-11-18 Sale |
2021-11-19 4:45 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
17,355 | $276.85 | $4,804,674 | 197,294 (Direct) |
View |
2021-11-10 Sale |
2021-11-12 5:12 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
4,783 | $263.93 | $1,262,355 | 91,247 (Direct) |
View |
2021-11-02 Sale |
2021-11-04 5:45 pm |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
2,285 | $295.87 | $676,070 | 12,337 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-09-08 Exercise |
2022-09-09 4:14 pm |
N/A 2028-02-29 |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
10,000 | $0 | 237,511 (Direct) |
View |
2022-09-08 Exercise |
2022-09-09 4:14 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
10,000 | $33.87 | 237,511 (Direct) |
View |
2022-08-16 Exercise |
2022-08-17 4:41 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
970 | $215.58 | 37,970 (Direct) |
View |
2022-08-16 Exercise |
2022-08-17 4:41 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
3,047 | $86.1 | 37,970 (Direct) |
View |
2022-08-16 Exercise |
2022-08-17 4:41 pm |
N/A 2030-02-27 |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
4,017 | $0 | 37,970 (Direct) |
View |
2022-08-11 Exercise |
2022-08-12 4:49 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
646 | $86.1 | 19,670 (Direct) |
View |
2022-08-11 Exercise |
2022-08-12 4:49 pm |
N/A 2026-12-14 |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
4,000 | $0 | 19,670 (Direct) |
View |
2022-08-11 Exercise |
2022-08-12 4:49 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
2,000 | $33.05 | 19,670 (Direct) |
View |
2022-08-11 Exercise |
2022-08-12 4:49 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
1,354 | $59.52 | 19,670 (Direct) |
View |
2022-08-03 Exercise |
2022-08-04 4:32 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
2,000 | $94.33 | 17,733 (Direct) |
View |
2022-08-03 Exercise |
2022-08-04 4:32 pm |
N/A 2030-04-01 |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
2,000 | $0 | 17,733 (Direct) |
View |
2022-07-21 Exercise |
2022-07-22 4:25 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
15,154 | $32.4 | 263,913 (Direct) |
View |
2022-07-21 Exercise |
2022-07-22 4:25 pm |
N/A 2028-02-29 |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
20,154 | $0 | 263,913 (Direct) |
View |
2022-07-21 Exercise |
2022-07-22 4:25 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
5,000 | $33.87 | 263,913 (Direct) |
View |
2022-05-26 Option Award |
2022-05-31 8:25 pm |
2023-05-26 2032-05-26 |
REPLIGEN CORP | RGEN | Mhatre Rohin Director |
4,122 | $0 | 4,579 (Direct) |
View |
2022-05-26 Option Award |
2022-05-31 8:23 pm |
2023-05-26 2032-05-26 |
REPLIGEN CORP | RGEN | Konstantinov Konstantin Director |
4,330 | $0 | 4,330 (Direct) |
View |
2022-05-26 Option Award |
2022-05-31 8:21 pm |
2023-05-26 2032-05-26 |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
2,209 | $0 | 78,741 (Direct) |
View |
2022-05-26 Option Award |
2022-05-31 8:20 pm |
2023-05-26 2032-05-26 |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
1,832 | $0 | 3,379 (Direct) |
View |
2022-05-26 Option Award |
2022-05-31 8:17 pm |
2023-05-26 2032-05-26 |
REPLIGEN CORP | RGEN | MUIR GLENN P Director |
1,832 | $0 | 8,194 (Direct) |
View |
2022-05-26 Option Award |
2022-05-31 8:15 pm |
2023-05-26 2032-05-26 |
REPLIGEN CORP | RGEN | EGLINTON MANNER CARRIE Director |
3,512 | $0 | 3,969 (Direct) |
View |
2022-05-13 Tax Withholding |
2022-05-17 5:00 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
712 | $150.4 | 20,110 (Direct) |
View |
2022-05-13 Tax Withholding |
2022-05-17 4:59 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
335 | $150.4 | 34,092 (Direct) |
View |
2022-05-13 Tax Withholding |
2022-05-17 4:59 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
712 | $150.4 | 39,187 (Direct) |
View |
2022-04-01 Tax Withholding |
2022-04-04 5:57 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
335 | $188.02 | 9,733 (Direct) |
View |
2022-03-08 Exercise |
2022-03-09 8:02 pm |
N/A 2028-03-01 |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
4,166 | $0 | 56,180 (Direct) |
View |
2022-03-08 Exercise |
2022-03-09 8:02 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
2,952 | $33.87 | 56,180 (Direct) |
View |
2022-03-08 Exercise |
2022-03-09 8:02 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
1,214 | $59.52 | 56,180 (Direct) |
View |
2022-03-01 Tax Withholding |
2022-03-03 3:52 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
7,292 | $194.06 | 199,315 (Direct) |
View |
2022-03-01 Exercise |
2022-03-02 9:14 pm |
N/A N/A |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
1,000 | $38.76 | 1,457 (Direct) |
View |
2022-03-01 Exercise |
2022-03-02 9:14 pm |
N/A 2030-11-11 |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
1,000 | $0 | 1,457 (Direct) |
View |
2022-02-27 Tax Withholding |
2022-03-02 8:19 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
2,534 | $196.7 | 20,822 (Direct) |
View |
2022-02-28 Option Award |
2022-03-02 8:19 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
4,234 | $0 | 20,822 (Direct) |
View |
2022-02-27 Tax Withholding |
2022-03-02 7:52 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
3,824 | $196.7 | 35,733 (Direct) |
View |
2022-02-28 Option Award |
2022-03-02 7:52 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
5,922 | $0 | 35,733 (Direct) |
View |
2022-02-27 Tax Withholding |
2022-03-02 7:49 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
19,292 | $196.7 | 206,607 (Direct) |
View |
2022-02-28 Option Award |
2022-03-02 7:49 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
30,074 | $0 | 206,607 (Direct) |
View |
2022-02-27 Tax Withholding |
2022-03-02 7:47 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
1,060 | $196.7 | 34,427 (Direct) |
View |
2022-02-24 Option Award |
2022-02-28 8:04 pm |
N/A 2032-02-24 |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
36,162 | $0 | 216,132 (Direct) |
View |
2022-02-24 Tax Withholding |
2022-02-28 8:04 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
1,170 | $189.21 | 216,132 (Direct) |
View |
2022-02-24 Option Award |
2022-02-28 7:10 pm |
N/A 2032-02-24 |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
7,853 | $0 | 38,045 (Direct) |
View |
2022-02-24 Tax Withholding |
2022-02-28 7:10 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
269 | $189.21 | 38,045 (Direct) |
View |
2022-02-24 Option Award |
2022-02-28 7:10 pm |
N/A 2032-02-24 |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
4,849 | $0 | 21,845 (Direct) |
View |
2022-02-24 Tax Withholding |
2022-02-28 7:10 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
188 | $189.21 | 21,845 (Direct) |
View |
2022-02-24 Option Award |
2022-02-28 7:09 pm |
N/A 2032-02-24 |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
4,845 | $0 | 38,208 (Direct) |
View |
2022-02-24 Tax Withholding |
2022-02-28 7:09 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
181 | $189.21 | 38,208 (Direct) |
View |
2022-02-24 Option Award |
2022-02-28 7:07 pm |
N/A 2032-02-24 |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
7,678 | $0 | 14,380 (Direct) |
View |
2022-02-24 Tax Withholding |
2022-02-28 7:07 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
188 | $189.21 | 14,380 (Direct) |
View |
2022-02-17 Option Award |
2022-02-22 7:37 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
900 | $0 | 6,890 (Direct) |
View |
2022-02-17 Tax Withholding |
2022-02-22 7:37 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
334 | $182.42 | 6,890 (Direct) |
View |
2022-02-17 Option Award |
2022-02-22 7:34 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
450 | $0 | 17,184 (Direct) |
View |
2022-02-17 Tax Withholding |
2022-02-22 7:34 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
175 | $182.42 | 17,184 (Direct) |
View |
2022-02-17 Option Award |
2022-02-22 7:31 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
450 | $0 | 33,544 (Direct) |
View |
2022-02-17 Tax Withholding |
2022-02-22 7:31 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
224 | $182.42 | 33,544 (Direct) |
View |
2022-02-17 Option Award |
2022-02-22 7:30 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
900 | $0 | 30,461 (Direct) |
View |
2022-02-17 Tax Withholding |
2022-02-22 7:30 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
332 | $182.42 | 30,461 (Direct) |
View |
2021-12-14 Tax Withholding |
2021-12-15 9:30 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
445 | $252.53 | 16,909 (Direct) |
View |
2021-11-18 Exercise |
2021-11-19 4:45 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
10,000 | $32.4 | 197,294 (Direct) |
View |
2021-11-18 Exercise |
2021-11-19 4:45 pm |
N/A 2027-02-23 |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
10,000 | $0 | 197,294 (Direct) |
View |
2021-11-10 Exercise |
2021-11-12 5:12 pm |
N/A N/A |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
4,783 | $26.12 | 91,247 (Direct) |
View |
2021-11-10 Exercise |
2021-11-12 5:12 pm |
N/A 2026-05-11 |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
4,783 | $0 | 91,247 (Direct) |
View |
2021-11-02 Exercise |
2021-11-04 5:45 pm |
N/A N/A |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
1,285 | $128.18 | 12,337 (Direct) |
View |
2021-11-02 Exercise |
2021-11-04 5:45 pm |
N/A 2030-05-13 |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
1,285 | $0 | 12,337 (Direct) |
View |